Cocrystal Pharma, Inc. SEC filings COCP
Cocrystal Pharma, Inc. has 672 filings in SEC EDGAR's recent list, going back to Sep 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 3 | Initial insider ownership | Aug 21, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 7, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 7, 2026 | — |
| 4 | Insider transaction | Aug 6, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 3, 2026 |
| 3 | Initial insider ownership | Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2026 | Jun 3, 2026 |
| DEFA14A | Additional proxy material | May 27, 2026 | — |
| DEF 14A | Proxy statement | May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 26, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| EFFECT | Filing | May 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| CORRESP | Letter to the SEC | Apr 29, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2026 | — |
| S-3 | Shelf registration | Apr 23, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2026 | Apr 2, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 30, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2025 | Dec 1, 2025 |
| 4 | Insider transaction | Nov 28, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 30, 2025 | — |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 4 | Insider transaction | Oct 30, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 30, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2025 | Oct 27, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 2, 2025 | — |
| 424B3 | Prospectus | Sep 29, 2025 | — |
| EFFECT | Filing | Sep 25, 2025 | — |
| CORRESP | Letter to the SEC | Sep 25, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| S-1 | Registration statement | Sep 19, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 15, 2025 | Sep 12, 2025 |
| 424B5 | Prospectus supplement | Sep 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2025 | Sep 12, 2025 |
| 424B3 | Prospectus | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 1, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | May 5, 2025 | — |
| DEF 14A | Proxy statement | May 5, 2025 | May 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Other events
|
Apr 1, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 31, 2024 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 18, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 28, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2024 | May 1, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 10-K/A | Amended annual report | Apr 17, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Agreement ended
|
Mar 1, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 2, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Dec 21, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 20, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Other events
|
Jun 15, 2023 | Jun 15, 2023 |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2023 | Jun 8, 2023 |
| EFFECT | Filing | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| S-3/A | Filing | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| S-3 | Shelf registration | May 12, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Apr 28, 2023 |
| 3 | Initial insider ownership | Apr 27, 2023 | Apr 20, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 24, 2023 | Apr 20, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Apr 12, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 10, 2023 | Apr 4, 2023 |
| 4 | Insider transaction | Apr 6, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Other events
|
Apr 4, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2023 | Mar 15, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 26, 2022 | Oct 25, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 3, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2022 | Sep 12, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 4 | Insider transaction | Aug 3, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2022 | May 18, 2022 |
| 8-K |
Current report
Listing notice
|
May 19, 2022 | May 17, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| DEF 14A | Proxy statement | Apr 11, 2022 | Apr 11, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2022 | Apr 1, 2022 |
| 10-K | Annual report | Mar 23, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2022 | Mar 23, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 4, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2021 | Dec 22, 2021 |
| 8-K |
Current report
Listing notice
|
Nov 19, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2021 | Sep 12, 2021 |
| 4 | Insider transaction | Aug 23, 2021 | Aug 20, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 20, 2021 | Jul 16, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COCP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bothell, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1412486
- Former names
- BIOZONE PHARMACEUTICALS, INC. (until Mar 25, 2014); International Surf Resorts, Inc. (until Mar 4, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.